Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer
Recruiting · NCT03853733 · Observational (researchers observe without assigning treatment) · Lead sponsor: Consorci Sanitari de Terrassa
View the official record on ClinicalTrials.gov →Interventions studied
rectal cancer radiotherapy
What this trial is about
Many patients with rectal cancer were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases. In this scenario only comfort measures or different palliative radiotherapy regimens are applied, from single doses to treatments lasting several weeks. The aim of this prospective study is to describe the preliminary results of our protocol of hypofractionated palliative radiotherapy in patients with non-operable rectal cancer.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with rectal or sigmoidal cancer who were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases at the time of diagnosis
- Patients with = or \> 18 years old
- Patients treated with a radiotherapy dose of 39Gy in 13 fractions of 3 Gy
Exclusion criteria
- Patients with a non rectum or sigma colo-rectal cancer.
- Patients with \<18 years old.
- Patients treated with concurrent chemotherapy
- Patients candidates for surgical resection after radiotherapy
Where it is running
1 location listed.
- Consorci Sanitari de Terrassa - Terrassa, Catalonia, Spain